- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HER2 -positive gastric cancer
Total 88864 results
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing CancersUnited States, Canada, Korea, Republic of
-
Zymeworks Inc.Active, not recruitingHER2-expressing CancersUnited States, Canada, Korea, Republic of, Australia
-
AC Camargo Cancer CenterTerminatedTrastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC (GASTHER2)Gastric Cancer Stage IVBrazil
-
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo CompanyAstraZenecaCompletedNeoplasm, Breast | Adenocarcinoma, GastricTaiwan
-
Pieris Pharmaceuticals, Inc.Active, not recruitingHER2-positive Gastric CancerUnited States, Korea, Republic of
-
Silverback TherapeuticsActive, not recruitingHER2 Positive Solid TumorsUnited States, Korea, Republic of, Australia
-
NYU Langone HealthWithdrawnStomach Cancer | Esophageal CancerUnited States
-
PrecirixCompleted
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHER2 Positive MalignanciesUnited States
-
Peking University Cancer Hospital & InstituteRecruitingHER2 Positive or Suspicious Positive TumorsChina
-
Alphamab (Australia) Co Pty Ltd.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsAustralia
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
Beijing 302 HospitalRecruiting
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruiting
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
Sunnybrook Health Sciences CentreMOUNT SINAI HOSPITAL; Princess Margaret Hospital, Canada; Trillium Health PartnersRecruiting
-
Peking University Cancer Hospital & InstituteNot yet recruitingMetastatic Castration-resistant Prostate Cancer
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Urothelium CancerChina
-
Universitair Ziekenhuis BrusselRecruitingCarcinoma | Receptor, ErbB-2Belgium
-
OnkoZentrum Zürich AGUniversity of Zurich; Palleos Healthcare GmbHCompletedHER2-positive Breast Cancer | Biosimilar | Patient Reported OutcomeSwitzerland
-
Spectrum Pharmaceuticals, IncTerminatedNSCLCUnited States, Canada, Netherlands, Belgium, Israel, Spain, France, Italy
-
Fudan UniversityCompleted
-
Samsung Bioepis Co., Ltd.TerminatedBreast NeoplasmsUkraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
-
Alpha Tau Medical LTD.TerminatedMetastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.PathologyRussian Federation
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
Yonsei UniversityCompletedHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedCarcinoma, Non-Small-Cell Lung | KRAS Gene Mutation | ALK Gene Mutation | BRAF Gene MutationFrance
-
Helsinki University Central HospitalActive, not recruiting
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
PfizerCompletedBreast NeoplasmsSpain, Korea, Republic of, United States, Australia, Italy, Russian Federation
-
NSABP Foundation IncGenentech, Inc.; International Drug Development InstituteCompleted
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastSpain, United States, Argentina, Austria, Italy, Russian Federation, Thailand, Brazil, Peru, Philippines, Hong Kong, Mexico
-
Zhejiang Medicine Co., Ltd.Ambrx, Inc.TerminatedStomach Neoplasms | Breast NeoplasmsAustralia, New Zealand
-
NantBioScience, Inc.Unknown
-
United BioPharmaTri-Service General HospitalCompleted
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, China, Hungary, Singapore, Australia, Russian Federation, Hong Kong, Brazil, Croatia, Korea, Republic of
-
First Affiliated Hospital of Harbin Medical UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownPancreatic Cancer | CARChina
-
Baylor Breast Care CenterAstraZenecaTerminated
-
AIO-Studien-gGmbHRoche Pharma AGCompletedAdenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the StomachGermany
-
British Columbia Cancer AgencyBC Cancer FoundationCompletedGastrointestinal Stromal Tumors | Colorectal Cancer Metastatic | Advanced Melanoma | Advanced Non-Small Cell Lung Carcinoma | Patients With Diagnosed Malignancies Being Considered for Clinical TrialsCanada
-
Galena Biopharma, Inc.CompletedBreast Cancer With Low to Intermediate HER2 ExpressionUnited States, United Kingdom, France, Israel, Germany, Canada, Russian Federation, Romania, Bulgaria, Czech Republic, Hungary, Poland, Ukraine
-
Genentech, Inc.Completed
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer | HER2+ Breast CancerBelgium, France, Spain, United States, United Kingdom, Italy
-
Genentech, Inc.CompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedFirst or Second Line HER2-negative Breast Cancer | Metastatic Disease Without Bone MetastasisUnited States
-
Biomedical Radiation SciencesSwedish Cancer SocietyCompleted